Missing/wrong data?
Log in to edit
Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia
Author/s
author: Zoe McQuilten, John F Seymour, Erica Wood, Robert Weinkove
Work details
Publication date
December 17, 2021
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.